The Massachusetts Senate unanimously passed a sweeping drug pricing and transparency bill Wednesday that supporters said would put the state at the forefront of a national effort to address skyrocketing drug costs.
The measure, dubbed the PACT Act 3.0, targets drug manufacturers and pharmacy benefit managers. They have been the subject of intense debates in statehouses and Congress, as lawmakers’ attempts to make life-saving drugs more accessible and affordable collided with the interests of some of the most deep-pocketed and influential industries in the country.
Already a subscriber? Sign in